We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$220M
AUM Growth
+$40.1M
Cap. Flow
+$16.3M
Cap. Flow %
7.42%
Top 10 Hldgs %
70.24%
Holding
28
New
2
Increased
7
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
ENTA icon
Enanta Pharmaceuticals
ENTA
+$16.5M
2
AMGN icon
Amgen
AMGN
+$4.41M
3
AVNS
Avanos Medical
AVNS
+$1.7M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.69M
5
UTHR icon
United Therapeutics
UTHR
+$915K

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$4.99M
2
MDCO
Medicines Co
MDCO
+$3.56M
3
ASRT
Assertio
ASRT
+$800K
4
IPXL
Impax Laboratories, Inc.
IPXL
+$486K
5
PFE icon
Pfizer
PFE
+$419K

Sector Composition

Rank Sector Weight
1 Healthcare 67.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
26
DELISTED
Medicines Co
MDCO
– –
-128,600
Closed -$3.56M
QLTI
27
DELISTED
QLT Inc
QLTI
– –
-17,000
Closed -$68K
1
2

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return

Krensavage Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Krensavage Asset Management held 28 positions worth $220M, up 22% from $179M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Krensavage Asset Management deployed $16.3M of net new capital in Q1 2015, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was Enanta Pharmaceuticals: 424,016 shares worth $13M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 66% a quarter earlier.

On the sell side, the largest reduction was Assertio, an estimated $800K trimmed.

  • Krensavage Asset Management's largest Q1 2015 buy was Enanta Pharmaceuticals: 424,016 shares worth $13M.
  • Krensavage Asset Management added most to Amgen in Q1 2015, an estimated $4.41M increase.
  • Krensavage Asset Management's biggest Q1 2015 reduction was Assertio, cutting an estimated $800K.
  • Krensavage Asset Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q1 2015, selling an estimated $4.99M.
  • Krensavage Asset Management's ten largest holdings make up 70% of its $220M portfolio in Q1 2015.
  • Krensavage Asset Management opened 2 new positions and closed 5 in Q1 2015.
  • Krensavage Asset Management's portfolio value rose 22% quarter-over-quarter to $220M.

Based on Krensavage Asset Management's 13F filing for Q1 2015, filed 13 May 2015.